Healthcare Industry News: YSGG technology
News Release - October 2, 2007
Cutera's New Laser, Pearl, Receives Health Canada Clearance
Pearl Renews Skin Surface with Few Treatments and Quick ResultsBRISBANE, Calif.--(HSMN NewsFeed)--Cutera, Inc.® (Nasdaq:CUTR ), a leading provider of laser and other light-based aesthetic systems for practitioners worldwide, today announced Health Canada approval for its new laser, Pearl, with proprietary YSGG technology. Pearl received FDA clearance in March 2007 and CE Mark approval in July 2007.
"We are pleased Pearl has received Canadian clearance, which means it meets all health, safety, and environmental standards required by Canada's Ministry of Health. We will immediately begin shipping Pearl into the Canadian market," said Kevin Connors, President and CEO of Cutera.
"I see Pearl as a big step forward in facial rejuvenation. There is nothing else like it on the market," said Kevin Smith, MD, Board-Certified Dermatologist in Ontario, Canada. "I can identify five to seven patients everyday who will benefit from Pearl because it provides effective and safe results for treating people with fine lines, irregular color and other signs of sun damage."
Pearl is a minimally invasive laser designed to improve the appearance of wrinkles, uneven texture, age spots and sun damage with only one or two treatments and minimal downtime. It is the first application of the 2790 nm wavelength for cosmetic dermatology.
Clinical data supports that Pearl's controlled thermal effect creates residual heat in the upper dermis that stimulates new collagen production. Pearl is expected to become a leading skin-rejuvenation procedure because of its patient-friendly approach and excellent clinical results. Pearl is available on Cutera's multi-application Xeo platform, as an upgrade to all existing customers, and as a standalone unit.
About Cutera, Inc.
Brisbane, Calif.-based Cutera is a leading provider of laser and other light-based aesthetic systems to the professional aesthetic market. Since 1998, Cutera has been developing innovative, easy-to-use products that enable dermatologists, plastic surgeons, gynecologists, primary care physicians and other qualified practitioners to offer safe and effective aesthetic treatments to their patients. For more information, call 1-888-4CUTERA or visit www.cutera.com.
This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Specifically, statements concerning the anticipated success of obtaining regulatory clearances, compiling effective clinical studies and making, marketing and selling new products are forward-looking statements within the meaning of the Safe Harbor. Forward-Looking statements are based on management's current, preliminary expectations and are subject to risks and uncertainties, which may cause Cutera's actual results to differ materially from the statements contained herein. Further information on potential risk factors that could affect Cutera's business and its financial results include its ability to improve sales productivity and increase sales performance worldwide; its ability to successfully develop and market new products; unforeseen events and circumstances relating to its operations; government regulatory actions; general economic conditions; and those other factors described in the section entitled, "Risk Factors," in its most recent Form 10-Q as filed with the Securities and Exchange Commission on August 6, 2007. Undue reliance should not be placed on forward-looking statements which speak only as of the date they are made. Cutera undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.
Source: Cutera
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!